Incidence of Hospitalization for Hypoglycemia Decreasing

Share this content:
Incidence of Hospitalization for Hypoglycemia Decreasing
Incidence of Hospitalization for Hypoglycemia Decreasing

FRIDAY, Dec. 2, 2016 (HealthDay News) -- For patients with type 1 diabetes, the incidence of hospitalization for hypoglycemia (HH) decreased over time in Denmark, with an 8.4 percent annual decrease, according to a study published online Nov. 29 in Diabetes Care.

Kazi Ishtiak-Ahmed, from the Steno Diabetes Center in Gentofte, Denmark, and colleagues used data for 17,230 patients with type 1 diabetes registered in the Danish Adult Diabetes Database from 2006 to examine nationwide incidence trends and predictors of HH. Patients were followed to 2012 (mean follow-up, 3.7 years).

The researchers found that there were 2,369 HH events among 1,735 patients with type 1 diabetes during 70,002 patient-years. With calendar time, there was a decrease in incidence rate, with an 8.4 percent annual decrease. Previous HH, age, diabetes duration, albuminuria, and glycated hemoglobin were predictors of HH.

"This study revealed a decreasing trend in incidence of HH in patients with type 1 diabetes," the authors write. "Previous HH, longer diabetes duration, macro-albuminuria, and HbA1c were associated with increased risk of HH in type 1 diabetes, and attention to those factors is warranted in both clinical and public health aspects."

Steno Diabetes Center is a hospital owned by Novo Nordisk; several authors disclosed financial ties to Novo Nordisk and other pharmaceutical companies.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »